The DCB currently remains an investigational device and is not available for sale in the US. "Airiver Medical receives FDA ...
There has been a medical breakthrough at UAB. A new study has discovered a possible root cause to preeclampsia.
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
Add Yahoo as a preferred source to see more of our stories on Google. From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer's disease, 2025 has been a year ...
Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI ...
Airiver Medical announced today that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB).
Medical Device Network on MSN
FDA grants breakthrough designation to PathAI for pathology solution
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
Hosted on MSN
From gene therapy breakthroughs to preventable disease outbreaks: The health trends that will shape 2026
Medicine stands at the precipice of an exciting new era. We're closer than ever to achieving functional cures for once-intracable diseases, including HIV. Stem-cell treatments are repairing blinding ...
Medical Device Network on MSN
Cognita secures FDA breakthrough device designation for CXR
Mosaic expects the collaboration with the FDA will help address diagnostic capacity constraints in the US healthcare system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results